Azirox 35ml dry syp

Azirox 35ml Dry Syrup — Azithromycin 200mg/5ml by Navana Pharmaceuticals

About Azirox 35ml Dry Syrup

Azirox 35ml Dry Syrup is an oral suspension of azithromycin 200 mg per 5 mL, presented as a dry powder that is reconstituted with water before use. Each 35 mL bottle (after reconstitution) contains 1400 mg of azithromycin — a distinctive pack size that bridges the 30 mL and 50 mL options available in the market. The 1400 mg total content makes Azirox 35ml the practical choice for a complete 5-day course in children weighing approximately 14–28 kg. Navana Pharmaceuticals Limited is a well-established Bangladeshi pharmaceutical manufacturer with GMP-certified production facilities. The dry powder formulation (reconstituted at the point of dispensing) ensures maximum drug stability prior to use, with shelf life maintained as long as the powder remains unmixed.

Dosing Table: Azirox 35ml at 10mg/kg/day

Azirox 35ml exactly covers a 5-day course for a 28kg child (7mL/day × 5 days = 35mL). For children over 28kg needing 5-day courses, the 50mL pack is required.

Acute Otitis Media in Children: Clinical Management

Acute otitis media (AOM) is one of the most frequently diagnosed bacterial infections in Bangladeshi children, particularly in the 6-month to 5-year age group. The primary bacterial causes are Streptococcus pneumoniae and non-typeable Haemophilus influenzae. Azithromycin suspension is a recommended alternative antibiotic for AOM in children with penicillin allergy (first-line remains amoxicillin 90mg/kg/day × 5–7 days or amoxicillin-clavulanate for high-risk cases). Azithromycin dosing for AOM: 10mg/kg/day × 3–5 days (most guidelines recommend 5 days for AOM rather than 3 days in children). Azirox 35ml suspension at 200mg/5mL is particularly well-suited for AOM treatment in children 15–28 kg. Criteria for AOM that benefit most from antibiotic treatment: children under 2 years with bilateral AOM, children with otorrhoea (ear discharge), and children with severe symptoms (high fever >39°C, severe otalgia). Watchful waiting may be appropriate for mild unilateral AOM in children over 2 years — discuss with your physician.

Azithromycin in Patients with Liver Disease — Safety Profile

Azithromycin is primarily eliminated via the biliary-faecal route — it is concentrated in the liver and excreted in bile, with less than 6% eliminated renally. This hepatic pathway is both an advantage and a consideration in patients with liver disease. In mild-to-moderate hepatic impairment (Child-Pugh A or B): azithromycin can generally be used at standard doses with clinical monitoring; the drug may accumulate slightly due to reduced biliary clearance, but this is rarely clinically significant for a 3–5 day course. In severe hepatic impairment (Child-Pugh C, severe cirrhosis, active hepatitis with significantly elevated bilirubin): azithromycin should be used with caution and only if the benefit clearly outweighs the risk — specialist input is recommended. For children with cholestatic jaundice, biliary atresia, or other significant hepatic conditions, azithromycin dose adjustment may be required — consult a paediatric gastroenterologist or hepatologist before use. Azithromycin-induced hepatotoxicity is rare but has been reported — if jaundice, right upper quadrant pain, or significantly elevated liver enzymes develop during a course, discontinue and seek medical assessment.

Frequently Asked Questions (FAQ)

Q1: What is the difference between a "dry syrup" and a regular syrup for azithromycin?
A dry syrup (also called dry powder for suspension) is supplied as a powder that must be mixed with water before use — the bottle contains dry azithromycin powder plus sweeteners, flavour, and suspending agents. A regular syrup is already in liquid form. The dry syrup format for Azirox 35ml offers important advantages: the unmixed powder is much more stable than a liquid preparation, with a longer shelf life (typically 2–3 years); the reconstituted suspension is used fresh (stable for 10 days), ensuring the patient always receives drug at full potency; and storage and transport are easier for dry powder than liquid. Always add cooled boiled water (not hot water, which may degrade the drug) to reconstitute Azirox 35ml dry syrup. The volume of water to add is specified on the label.

Q2: My child has penicillin allergy — is Azirox 35ml dry syrup safe?
Yes, azithromycin is a macrolide antibiotic (not a beta-lactam) and has no cross-reactivity with penicillin or other beta-lactam antibiotics (cephalosporins, carbapenems). Azirox 35ml dry syrup is a safe and appropriate antibiotic alternative for children with confirmed penicillin allergy. The most common side effects of azithromycin suspension in children are gastrointestinal: nausea, loose stools, abdominal cramps. These are generally mild and transient. Severe allergic reactions (anaphylaxis) to azithromycin itself are very rare but possible — if your child develops rash, facial swelling, or breathing difficulty after the first dose, seek emergency medical attention immediately.

Q3: How does azirox 35ml suspension taste, and how can I make it easier for my child to take?
Azirox suspension is formulated with sweeteners and flavouring to make it palatable for children. Individual taste preferences vary — some children readily accept the suspension while others may resist. Strategies to improve acceptance: ensure the suspension is well-shaken and at room temperature or slightly chilled before giving; use a calibrated oral syringe and administer the dose into the side of the child's cheek (not the back of the throat) to reduce the gag reflex; follow the dose immediately with a small amount of the child's favourite drink; and give the dose at a time when the child is cooperative and not excessively tired or hungry. Mixing the measured dose into a small amount (5mL) of cold fruit juice or squash (administered from a separate cup) immediately before giving is acceptable — do not pre-mix and store.

Q4: Can Azirox 35ml dry syrup be used for tonsillitis?
Yes — azithromycin suspension is an effective treatment for streptococcal tonsillitis/pharyngitis (Group A Streptococcus) as a second-line alternative for children with penicillin allergy. The dose is 10mg/kg/day for 5 days. First-line for streptococcal tonsillitis remains amoxicillin (50mg/kg/day × 10 days) or phenoxymethylpenicillin (penicillin V) — these achieve slightly higher bacteriological eradication rates than azithromycin. Azirox 35ml is recommended for: children with confirmed penicillin allergy; children who have failed prior amoxicillin courses for tonsillitis; or children in households where azithromycin was chosen for its once-daily, 5-day regimen (simpler than twice-daily amoxicillin × 10 days). If symptoms do not improve within 48 hours or worsen, reassess for complications (peritonsillar abscess, scarlet fever).

Medical Disclaimer: Azirox 35ml Dry Syrup dosing must be weight-based and prescribed by a physician or pharmacist. Add the exact volume of cooled boiled water as specified on the label. Discard reconstituted suspension after 10 days. Navana Pharmaceuticals Limited product.